Aethlon Medical Stock Today
| AEMD Stock | USD 1.25 0.69 35.57% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Aethlon Medical is trading at 1.25 as of the 29th of June 2025, a 35.57 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.2. Aethlon Medical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 31st of March 2025 and ending today, the 29th of June 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 2nd of January 2001 | Category Healthcare | Classification Health Care |
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 2.01 M outstanding shares of which 28.33 K shares are presently shorted by private and institutional investors with about 0.66 trading days to cover. More on Aethlon Medical
Moving against Aethlon Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aethlon Stock Highlights
| CFO, CEO | James MBA | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsAethlon Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aethlon Medical's financial leverage. It provides some insight into what part of Aethlon Medical's total assets is financed by creditors.
| |||||
Aethlon Medical (AEMD) is traded on NASDAQ Exchange in USA. It is located in 11555 Sorrento Valley Road, San Diego, CA, United States, 92121 and employs 14 people. Aethlon Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.51 M. Aethlon Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 2.01 M outstanding shares of which 28.33 K shares are presently shorted by private and institutional investors with about 0.66 trading days to cover.
Aethlon Medical currently holds about 14.92 M in cash with (7.65 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65.
Check Aethlon Medical Probability Of Bankruptcy
Ownership AllocationAlmost 77.92 percent of Aethlon Medical outstanding shares are held by general public with 0.94 (percent) owned by insiders and only 21.14 % by other corporate entities.
Check Aethlon Ownership Details
Aethlon Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Citadel Advisors Llc | 2025-03-31 | 14.1 K | |
| Baader Bank Inc | 2025-03-31 | 11.5 K | |
| Blackrock Inc | 2025-03-31 | 7.3 K | |
| Group One Trading, Lp | 2025-03-31 | 1.2 K | |
| Wells Fargo & Co | 2025-03-31 | 211 | |
| Advisor Group Holdings, Inc. | 2025-03-31 | 149 | |
| Bank Of America Corp | 2025-03-31 | 123 | |
| Morgan Stanley - Brokerage Accounts | 2025-03-31 | 89.0 | |
| Sbi Securities Co Ltd | 2025-03-31 | 39.0 | |
| Armistice Capital, Llc | 2025-03-31 | 1.4 M | |
| Ikarian Capital, Llc | 2025-03-31 | 1.2 M |
Aethlon Medical Historical Income Statement
Aethlon Stock Against Markets
Aethlon Medical Corporate Management
| Michele Bombardiere | VP Controller | Profile | |
| Richard Tullis | Chief Science Officer and VP | Profile | |
| MBA BS | Chief Officer | Profile | |
| MD Fisher | Director CEO | Profile | |
| Steven MD | Chief Officer | Profile | |
| Lee Arnold | Chief Officer | Profile |
Already Invested in Aethlon Medical?
The danger of trading Aethlon Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aethlon Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aethlon Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aethlon Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.58) | Revenue Per Share | Quarterly Revenue Growth 42.782 | Return On Assets | Return On Equity |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.